Keynote speaker: Andrew Thompson, co-founder and CEO, Proteus Biomedical: "Beyond the Rich"
Opened noting the high cost of innovation in Healthcare vs. low return (1/1000 Lipitor users will realize significant benefits from use cited) and emphasized the need to improve; the business model used by the Heathcare Industry is antiquated and needs to follow the electronics Industry, being more consumer-oriented rather than healthcare professionals dealing with only each other; there is a critical need to develop an ability to eliminate black-market counterfeit pharmaceuticals, which is a major issue in most of the world; Proteus' product is a computer chip intended to be taken with a given drug internally fed by the body's normal nutrients, ushering in an era of "Intelligent Pharmaceuticals"; wireless communication can be transmitted to cell phone apps etc., guaranteeing drug integrity and effects with output parameters such as heartbeat, drug concentrations in the bloodstream, etc.; enables direct feedback to consumers; the data can be extended to external performance activites such as sports, video gaming, etc.; the "Intelligent Pharmaceutical" market is expected to reach major revenues, multi-bilion $, by 2020
No comments:
Post a Comment